• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Selective α1 Blocker
    3 Drugs classified under this drug class

    All the Drug Class Drugs

    Cadex 1 mg, 2 mg, 4 mg
    partial basket chart
    Cadex 1 mg, 2 mg, 4 mg

    Selective α1 Blocker. Doxazosin (as mesylate) 1 mg, 2 mg, 4 mg.
    TAB.: 30 x 1mg,
    CAPLETS: 30 x 2mg, 4mg. Hypertens.: once dly. regimen. initial: 1mg. may incr. aft. 1-2 wks. to 2 mg and then if necessary to 4 mg, 8mg or 16 mg (max.dose).
    BPH: init.: 1 mg x 1 dly. Once dly. May
    incr.to 2 mg, then to 4 mg and then 8
    mg (max. recommend. Dose). All 1 x
    dly. The recomm. titrat. Interval: 1-2
    wks. Usual recom. dly. dose: 2-4 mg.
    see lit.
    Hypertens., B.P.H
    C/I: Pts. with a known hypersens. to
    quinazolines (e.g. prazosin, terazosin,
    doxazosin), or any of the ingredients.
    Pts. with a history of orthostatic
    hypotens. Pts. with BPH and concom. congest. of the upper urin. tract, chronic urin. tract infec. or bladder stones.
    Lact. Pts. with hypotens. (for BPH only).
    monother. in pts. with either overflow
    bladder or anuria with or without
    progress. renal insuffic. See Lit.

    partial basket chart

    Selective α1 Blocker. Terazosin (as monohydrochloride dihydrate) 2 mg.
    TABS: Starter Pack: 7 x 1 mg, 2 mg. 28 x 5 mg, 10 mg. Initial: 1 x 1 mg tab 1 x
    dly at bedt. Incr. step-wise to 2 mg, 5 mg
    or 10 mg 1 x dly to achieve desired
    Sympt. tmt. urinary obstruct. caused by
    BPH, mild to mod. hypertens.

    Terazosin Teva
    not in the basket chart
    Terazosin Teva

    Selective α1 Blocker. Terazosin HCl dihydrate 1, 2, 5 mg.
    TABS: 30 x 2mg, 5 mg. If discont. for
    several days, tmt. should be reinstitut.
    start. initial dos. regimen. BPH: Initial:
    1 mg at bedt., not to be exceed.
    Monitor during initial admin., risk of
    severe hypotens. Incr. stepwise to 2
    mg, 5 mg or 10 mg 1 x dly. 10 mg 1 x
    dly gen. req. for clin. response. Cont.
    for min. 4-6 wks. to assess benefic.
    response. Caution dur. concom. admin.
    other antihypertens., espec. verapamil,
    to avoid hypotens. Dose reduct./
    retitrat. may be necess. Hypertens:
    Adjust dose (12/24 hrs) acc. pts. BP
    response. Initial: 1 mg at bedt., not to
    be exceed. Monitor during initial
    admin., risk of severe hypotens. May
    be slowly incr., 1 mg-5 mg 1 x dly,
    some pts. 20 mg/day. Monitor BP at
    end of dos. interval; also 2-3 hrs. after
    dosing for excessive hypotens.
    response. If response is diminished at
    24 hrs, consider incr. dose or 2 x dly
    reg. Except initial dose, admin. in
    Symptomat. tmt. urinary obstruct.,
    caused by BPH. Mild-mod. hypertens.
    C/I: Known hypersens.